First Generic EpiPen Autoinjector Gains FDA Approval
Mylan’s EpiPen and EpiPen Jr epinephrine autoinjectors are the first generic versions to gain FDA approval, in a move that can help increase access to emergency treatment for allergic reactions; and is part of broader federal mandates to help lower costs of medications that not protected by patents or exclusions. Approval was granted for Teva …